From improved survival to potential cure in patients with metastatic breast cancer

Breast Cancer

Volumn 19, Issue 3, 2012, Pages 187-190

  Kobayashi, Tadashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; AROMATASE INHIBITOR; CAPECITABINE; DOXORUBICIN; NAVELBINE; PACLITAXEL; TRASTUZUMAB;

BREAST CANCER; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE INTERVAL; HUMAN; MOLECULARLY TARGETED THERAPY; MULTIMODALITY CANCER THERAPY; OLIGOMETASTATIC BREAST CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; TIME FACTORS;

EID: 84866383419     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0307-0     Document Type: Review

References (17)

1. Tan S-H, Wolff AC. Treatment of metastatic breast cancer: chemotherapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010. p. 877-919.
2. Hortobagyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol. 2001;20:620-3.
3. Hayes DF. General principles of management of metastatic breast cancer. Up To Date 2010; version 18.3.
4. Güth U, Huang DJ, Dirnhofer S, Rochlitz C, Wight E. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision. Cancer J. 2009;15:81-6.
5. Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst. 2010;102:456-63.
6. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996;14:2197-205. (Pubitemid 26264869)
7. Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, et al. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin- containing chemotherapy. Cancer. 1999;85:104-11. (Pubitemid 29031363)
8. Todd M, Shoag M, Cadman E. Survival of women with metastatic breast cancer at Yale from 1920 to 1980. J Clin Oncol. 1983;1:406-8. (Pubitemid 14181202)
9. Patel JK, Nemoto T, Vezeridis M, Petrelli N, Suh O, Dao TL. Does more intense palliative treatment improve overall survival in metastatic breast cancer patients? Cancer. 1986;57:567-70.
10. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer. 2004;100:44-52.
11. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22:3302-8. (Pubitemid 41103686)
12. Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;110:973-9. (Pubitemid 47312861)
13. Mauri D, Polyzos NP, Salanti G, Pavlidis N, Ioannidis JP. Multiple- treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst. 2008;100:1780-91.
14. Burstein HJ, Harris JR, Morrow M. Malignant tumors of the breast. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer. 8th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. p. 1606-54.
15. Swenerton KD, Legha SS, Smith T, Hortobagyi GN, Gehan EA, Yap HY, et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979; 39:1552-62. (Pubitemid 9172673)
16. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8-10.
17. Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors. Cancer. 2005;104:1158-71. (Pubitemid 41278950)